This week's videos
I posted three videos this week.
What do I do? Here's a summary of a typical Thursday:
How do I stay focused (and optimistic)?
We're going to run the first trial as an adaptive clinical trial. Why?
Typically an adaptive design is used to pick a dose, select one out of several drugs to test or define the population to study. We're using this design so we can generate and share the initial clinical data sooner - a key step to getting more investment and support.
More to come!
Share This
|
Sign up at: ParkinsonsDisease.blog |
About Jonathan Sackner-Bernstein, MD
Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD.
Dr. S-B’s Linkedin page
RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.